Skip to content
  • Home
  • About Us
  • Longevity Platform
  • Bio101
    • BIO101 in Sarcopenia
    • BIO101 in Obesity
  • Biophytis Biopharmaceutical
  • Other Projects
  • Resources
    • Posters & Publications
    • Scientific Press Releases
  • Recruitment
  • Investors
    • Stock Information
    • Corporate Presentation
    • Letter to shareholders
    • Press Releases
    • General Meetings
    • AMF Regulated Information
    • SEC Filings
    • Convertible bonds
    • Pre-financed vouchers (PFW)
    • Obligations Hexagon
    • Obligations Hexagon
    • Contact for Investors
  • Contact

    TNC FlipBook Classic items

    01092025_CP_Planning_etude_OBA

    By adminAugust 31, 2025

    28082025_PR_Approval_EMA_Biophytis_Phase_3_SARA

    By adminAugust 28, 2025

    28082025_CP_Autorisation_EMA_Biophytis_Phase_3_SARA

    By adminAugust 28, 2025

    2025-08-05_PR_Financement_Hexagon_EN

    By adminAugust 25, 2025

    2025-08-05_CP_Financement_Hexagon_FR

    By adminAugust 25, 2025

    300725-CP-Deฬmeฬnagement-Biophytis_FR

    By adminJuly 29, 2025

    300725-PR-SilverInnov_EN

    By adminJuly 29, 2025

    16072025_PR_Biophytis_x_Negma_EN

    By adminJuly 15, 2025

    16072025_CP_Biophytis_x_Negma_FR

    By adminJuly 15, 2025

    Partnership_LYNX_BIOPHYTIS_AI_July_2025_EN

    By adminJuly 15, 2025
    โ†1
    23456789101112131415161718
    …1920212223…
    24252627282930313233
    34โ†’
    X
    Addresses
    Addresses

    BIOPHYTIS France
    Silver Innov’
    54 rue Moliรจre
    94200 Ivry-Sur-Seine
    FRANCE

    Addresses

    BIOPHYTIS USA
    c/o NGIN
    210 Broadway, Suite #201
    Cambridge, MA 02139
    USA

    Addresses

    BIOPHYTIS Brazil
    CIETEC
    Av. Prof. Lineu Prestes
    2242 Cidade Universitรกria USP
    05508-000 Sรฃo Paulo
    BRASIL

    Contact
    contact@biophytis.com +33 1 76 28 40 83
    Investors

    investors@biophytis.com

    ยฉ Biophytis 2025.

    All Rights Reserved.

    Legal information
    Webdesign by Ex Calibra
    Go to Top
    • Home
    • About Us
    • Longevity Platform
    • Bio101
      • BIO101 in Sarcopenia
      • BIO101 in Obesity
    • Biophytis Biopharmaceutical
    • Other Projects
    • Resources
      • Posters & Publications
      • Scientific Press Releases
    • Recruitment
    • Investors
      • Stock Information
      • Corporate Presentation
      • Letter to shareholders
      • Press Releases
      • General Meetings
      • AMF Regulated Information
      • SEC Filings
      • Convertible bonds
      • Pre-financed vouchers (PFW)
      • Obligations Hexagon
      • Obligations Hexagon
      • Contact for Investors
    • Contact
    • Home
    • About Us
    • Longevity Platform
    • Bio101
      • BIO101 in Sarcopenia
      • BIO101 in Obesity
    • Biophytis Biopharmaceutical
    • Other Projects
    • Resources
      • Posters & Publications
      • Scientific Press Releases
    • Recruitment
    • Investors
      • Stock Information
      • Corporate Presentation
      • Letter to shareholders
      • Press Releases
      • General Meetings
      • AMF Regulated Information
      • SEC Filings
      • Convertible bonds
      • Pre-financed vouchers (PFW)
      • Obligations Hexagon
      • Obligations Hexagon
      • Contact for Investors
    • Contact